111 related articles for article (PubMed ID: 23544673)
1. Impaired fasting glucose in hypertensive patients: prevalence and cross-sectional analysis of associations with cardiovascular disease.
Tziomalos K; Spanou M; Baltatzi M; Efthymiou E; Psianou K; Papastergiou N; Iliadis F; Didangelos TP; Savopoulos C; Hatzitolios AI
Diabetes Technol Ther; 2013 Jun; 15(6):475-80. PubMed ID: 23544673
[TBL] [Abstract][Full Text] [Related]
2. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
[TBL] [Abstract][Full Text] [Related]
3. Impaired fasting glucose and impaired glucose tolerance do not predict hypertension: a community cohort study.
Lee CJ; Lim NK; Kim HC; Ihm SH; Lee HY; Park HY; Park S
Am J Hypertens; 2015 Apr; 28(4):493-500. PubMed ID: 25267735
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
Kim SH; Chunawala L; Linde R; Reaven GM
J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease.
Marín R; Rodríguez P; Tranche S; Redón J; Morales-Olivas F; Galgo A; Brito MA; Mediavilla J; Lozano JV; Filozof C;
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S178-88. PubMed ID: 17130259
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of diabetes and impaired fasting glucose in Costa Rica: Costa Rican National Cardiovascular Risk Factors Survey, 2010.
Wong-McClure R; Gregg EW; Barcelo A; Sanabria-Lopez L; Lee K; Abarca-Gomez L; Cervantes-Loaiza M; Luman ET
J Diabetes; 2016 Sep; 8(5):686-92. PubMed ID: 26516694
[TBL] [Abstract][Full Text] [Related]
7. [Impact of new criterion of glucose level on the prevalence of impaired fasting glucose and risk of ischemic cardiovascular diseases].
Wang W; Zhao D; Sun JY; Liu J; Qin LP; Wu ZS
Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):20-4. PubMed ID: 17331382
[TBL] [Abstract][Full Text] [Related]
8. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
[TBL] [Abstract][Full Text] [Related]
9. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of diabetes and impaired fasting glucose in hypertensive adults in rural China.
Sun Z; Zheng L; Xu C; Zhang X; Li J; Liu S; Li J; Hu D; Sun Y
Acta Cardiol; 2009 Jun; 64(3):351-6. PubMed ID: 19593946
[TBL] [Abstract][Full Text] [Related]
11. [Impaired fasting glycaemia as a risk factor of coronary heart disease].
Sultanova SS
Georgian Med News; 2012 Oct; (211):33-7. PubMed ID: 23131980
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic.
Salmasi AM; Alimo A; Dancy M
Am J Hypertens; 2004 Jun; 17(6):483-8. PubMed ID: 15177519
[TBL] [Abstract][Full Text] [Related]
13. Incidence and predictors of abnormal fasting plasma glucose among the university hospital employees in Thailand.
Jiamjarasrangsi W; Lohsoonthorn V; Lertmaharit S; Sangwatanaroj S
Diabetes Res Clin Pract; 2008 Feb; 79(2):343-9. PubMed ID: 17953998
[TBL] [Abstract][Full Text] [Related]
14. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
Guerrero-Romero F; Violante R; Rodríguez-Morán M
Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
[TBL] [Abstract][Full Text] [Related]
15. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
16. [Associated factors of impaired fasting glucose in some Korean rural adults].
Yun HE; Han MA; Kim KS; Park J; Kang MG; Ryu SY
J Prev Med Public Health; 2010 Jul; 43(4):309-18. PubMed ID: 20689357
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
18. [Use of antihypertensive drugs in France and relationship with cardiovascular disease. FLAHS 2009-2010 surveys].
Girerd X; Laroche P; Hanon O; Pannier B; Postel-Vinay N; Mourad JJ
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):213-7. PubMed ID: 22695024
[TBL] [Abstract][Full Text] [Related]
19. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
[TBL] [Abstract][Full Text] [Related]
20. The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population.
Noto D; Barbagallo CM; Cefalù AB; Falletta A; Sapienza M; Cavera G; Amato S; Pagano M; Maggiore M; Carroccio A; Notarbartolo A; Averna MR
Atherosclerosis; 2008 Mar; 197(1):147-53. PubMed ID: 17466306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
